- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|Compound 8i is a multi-target receptor tyrosine kinase inhibitor . The chemical structure matches that ascribed to the Exelixis compound XL999 presented by MedKoo, but there is no peer reviewed confirmation of this nomenclature linkage.
Compound 8i does not alter c-MET activity, so its effects can be compared to those of foretinib and/or cabozantinib which are c-MET inhibitors, to help assess the contribition that inhibition of the different kinases makes to measured outcomes (e.g. antiproliferative effect).
|GtoPdb PubChem SID||363894199|
|Search Google for chemical match using the InChIKey||DMQYDVBIPXAAJA-VHXPQNKSSA-N|
|Search Google for chemicals with the same backbone||DMQYDVBIPXAAJA|
|Search UniChem for chemical match using the InChIKey||DMQYDVBIPXAAJA-VHXPQNKSSA-N|
|Search UniChem for chemicals with the same backbone||DMQYDVBIPXAAJA|